Concepedia

Author

Eleftheria Tsolaki

Aristotle University of ThessalonikiORCID

Also Known As

E Tsolaki, E. Tsolaki, ELEFTHERIA TSOLAKI, Eleftheria Tsolaki, Tsolaki, Eleftheria

48

Publications

468

Citations

12

H-Index

42

Concepts

All Affiliations

Aristotle University of ThessalonikiUniversity of PatrasHippocration General HospitalPapageorgiou General HospitalHospital Agioi Anargyroi
ET

About

Eleftheria Tsolaki is an author at Aristotle University of Thessaloniki specializing in medicine, pathology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

199

2

Cell Biology

4

4

177

3

Health Sciences

2

2

126

4

Engineering

1

1

43

5

Language Studies

1

1

11

Eleftheria Tsolaki

×

13

Publications

363

Citations

11

H-Index

YearCitations

Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury.

Angeliki Xagorari, Eleni Siotou, Minas Yiangou,

PubMed

2013

76

Hematopoietic stem cells and liver regeneration: Differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury

Eleftheria Tsolaki, Evangelia Athanasiou, Eleni Gounari,

Blood Cells Molecules and Diseases

2014

50

Harmful microalgal episodes in Greek coastal waters

Georgios Nikolaidis, Κωνσταντίνος Κουκάρας, Katerina Aligizaki,

Journal of Biological Research

2005

43

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

George Fountzilas, Urania Dafni, Mattheos Bobos,

BMC Cancer

2013

33

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab

Evangelia Razis, George Pentheroudakis, George S. Rigakos,

Journal of Cancer Research and Clinical Oncology

2014

33

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

Helen Gogas, Vassiliki Kotoula, Zoi Alexopoulou,

Journal of Translational Medicine

2016

27

Prevalent somatic <i>BRCA1</i> mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe

George Fountzilas, Amanda Psyrri, Eleni Giannoulatou,

International Journal of Cancer

2017

22

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes

Vassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri,

Breast Cancer Research and Treatment

2016

18

Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)

George Pentheroudakis, Vassiliki Kotoula, Anastasia G Eleftheraki,

PLoS ONE

2013

15

Evaluation of Two Highly-Multiplexed Custom Panels for Massively Parallel Semiconductor Sequencing on Paraffin DNA

Vassiliki Kotoula, Aggeliki Lyberopoulou, Kyriaki Papadopoulou,

PLoS ONE

2015

13

Page 1